Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Biomerica Inc (BMRA)

Biomerica Inc (BMRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Biomerica Inc 17571 Von Karman Avenue Irvine CA 92614 USA

www.biomerica.com P: 949-645-2111

Description:

BIOMERICA, INC. is an emerging-growth biotechnology firm that develops, manufactures and distributes medical diagnostic products. The Company is focused on niche products for early detection and monitoring of human diseases and conditions before they become catastrophic and incurable. The customers include medical universities, pharmaceutical companies, hospitals, clinics, commercial laboratories, physician's offices and consumers.

Key Statistics

Overview:

Market Capitalization, $K 11,362
Enterprise Value, $K 1,642
Shares Outstanding, K 16,822
Annual Sales, $ 5,340 K
Annual Net Income, $ -7,140 K
Last Quarter Sales, $ 1,020 K
Last Quarter Net Income, $ -1,920 K
EBIT, $ -6,680 K
EBITDA, $ -6,330 K
60-Month Beta -1.04
% of Insider Shareholders 13.50%
% of Institutional Shareholders 22.28%
Float, K 14,551
% Float 86.50%
Short Volume Ratio 0.28

Growth:

1-Year Return -46.35%
3-Year Return -85.51%
5-Year Return -71.46%
5-Year Revenue Growth -3.96%
5-Year Earnings Growth -194.12%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.11 on 04/12/24
Latest Earnings Date N/A
Earnings Per Share ttm -0.37
EPS Growth vs. Prev Qtr -22.22%
EPS Growth vs. Prev Year 8.33%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

BMRA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -64.00%
Return-on-Assets % -50.95%
Profit Margin % -133.71%
Debt/Equity 0.00
Price/Sales 2.25
Price/Cash Flow N/A
Price/Book 1.56
Book Value/Share 0.46
Interest Coverage -0.16
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar